Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

		Cancer Friends Network > Types of Cancer > Head and Neck Cancer
Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-27-2012, 08:38 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

Boehringer Ingelheim announced today the initiation of two phase III clinical trials, LUX-Head & Neck 1 and LUX-Head & Neck 2. These trials evaluate afatinib in patients with metastatic and recurrent head and neck cancer, and in patients with locally advanced disease, respectively.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 10:57 AM.

CancerFriends.net